DTIL:NASDAQ
Precision BioSciences Inc
$6.50
arrow_upward
+1.40%(+0.090) 1D
$6.50
0.00% (0.00)
bedtimeAfter hours
Closed: Jun 5, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DTIL...
Open
$6.36
High
$6.50
Low
$6.10
Mkt. cap
167.71M
Avg. vol.
274.98K
Volume
253.33K
52-wk high
$8.82
52-wk low
$3.53
EPS
-$3.67
Beta
1.30
Shares outstanding
25.80M
No. of employees
66
Open
$6.36
High
$6.50
Low
$6.10
Mkt. cap
167.71M
Avg. vol.
274.98K
Volume
253.33K
52-wk high
$8.82
52-wk low
$3.53
EPS
-$3.67
Beta
1.30
Shares outstanding
25.80M
No. of employees
66
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to DTIL in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DTIL in the last 3 months.
Highest
Current $6.50
$60.00 (+823.08%)
Average
$36.33 (+458.92%)
Lowest
$19.00 (+192.31%)
News stories
From sources across the web
Simply Wall Street
·
1 hour ago
Fluence Energy Board Reshuffle Deepens AES Influence On Growth Priorities
MarketBeat
·
22 minutes ago
Pinebridge Investments LLC Invests $19.51 Million in Nasdaq, Inc. $NDAQ
Seeking Alpha
·
1 hour ago
S&P 500: This Is Not A Dip Yet (Rating Downgrade) (SPX)
Profile
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
About Precision BioSciences Inc
AI content may include mistakes. Learn more